Skip to content
10-Q

Quarterly Report

SAFECODE DRUG TECHNOLOGIES CORP.

0001558891-13-000165

← back to feed
Filed
Aug 13, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Jun 30, 2013 143.37M sh
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$35.79K
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$359.98K
Stockholders Equity Q2 2013 · Jun 30, 2013 −$89.99K
Stockholders Equity Q2 2013 · Dec 31, 2012 $112.66K
Current Liabilities Q2 2013 · Jun 30, 2013 $200.91K
Current Liabilities Q2 2013 · Dec 31, 2012 $61.67K
Total Liabilities Q2 2013 · Jun 30, 2013 $200.91K
Total Liabilities Q2 2013 · Dec 31, 2012 $61.67K
Current Assets Q2 2013 · Jun 30, 2013 $919
Current Assets Q2 2013 · Dec 31, 2012 $174.33K
Total Assets Q2 2013 · Jun 30, 2013 $110.92K
Total Assets Q2 2013 · Dec 31, 2012 $174.33K
Net Income Q2 2013 · Jun 30, 2013 −$236.57K
Net Income Q2 2013 · Jun 30, 2013 −$799.56K
Net Income Q2 2013 · Jun 30, 2013 −$2.92M
Operating Income Q2 2013 · Jun 30, 2013 −$193.43K
Operating Income Q2 2013 · Jun 30, 2013 −$698.65K
Operating Income Q2 2013 · Jun 30, 2013 −$2.79M